LigaChem Biosciences stock price

리가켐바이오KRX:141080 · KOSDAQ · Healthcare · sector #23
₩73,800-8.32%
2026-10-08 close
Loading chart…

LigaChem Biosciences's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.

LigaChem Biosciences last closed at ₩73,800 (-8.32%) on 2026-10-08. Listed on KOSDAQ. Trailing 12 months PER is -14.9×. Its overall grade ranks 283 of 308 stocks in Healthcare.

About this company

LigaChem Biosciences last closed at ₩73,800 (-8.32%) on 2026-10-08. Listed on KOSDAQ.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall F · 283/308

Valuation grade C+

Details →

Recent filings

DART · received recent list, not a complete filing history. Factual information, not investment advice.

Details →

Related stocks

  • 항체-약물접합체(ADC) 분야 글로벌 경쟁사

  • SeagenCompetitor

    ADC 대표 기업으로 같은 테마의 핵심 경쟁사

  • Daiichi SankyoCompetitor

    ADC 파이프라인 강자로 리가켐바이오와 같은 분야 경쟁

Details →

ETFs holding this stock

HANARO 바이오코리아액티브 · TIME K바이오액티브 · TIGER 코스닥150바이오테크

Details →
About LigaChem Biosciences
What technical signals does LigaChem Biosciences (141080) have?
LigaChem Biosciences current technical signals: no active technical signal.
Is LigaChem Biosciences a cup-and-handle pattern?
No. LigaChem Biosciences has no valid Cup signal right now.
What published figures are available for LigaChem Biosciences?
Market cap: KRW 2.7T. Trailing 12 months PER: -14.9×. Latest quarter PBR: 6.67×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-09 dataset

Turn what you saw on this name into a strategy

Ask Q about LigaChem Biosciences, or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

LigaChem Biosciences notifications

Quantus Signal · live data · not investment advice · Privacy Policy